An Open-label, Cross-over, Pharmacokinetic Study to Assess the Safety and Pharmacokinetics of Transdermal Granisetron (Sancuso Patch) and IV Granisetron in a Pediatric Oncology Population (Aged 6 to 12 Years)

Status: Withdrawn prior to enrolment

Phase of Trial: Phase I

Latest Information Update: 23 Mar 2021

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Granisetron (Primary) ; Granisetron (Primary)
Indications Chemotherapy-induced nausea and vomiting
Focus Pharmacokinetics
Sponsors Kyowa Kirin International; Kyowa Kirin Pharmaceutical Development

Most Recent Events

18 Mar 2021 Status changed from not yet recruiting to withdrawn prior to enrolment as the company currently does not have plans to conduct this study.
06 Jan 2020 Planned End Date changed from 1 Dec 2017 to 31 Aug 2020.
06 Jan 2020 Planned primary completion date changed from 1 Dec 2017 to 31 Aug 2020.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com

Welcome to AdisInsight